5-(1-methyl-1H-imidazol-4-yl)-3-(4-(1-methyl-1H-pyrazol-4-yl)benzyl)-1H-indazole

ID: ALA3775519

Chembl Id: CHEMBL3775519

PubChem CID: 127031177

Max Phase: Preclinical

Molecular Formula: C22H20N6

Molecular Weight: 368.44

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cn1cnc(-c2ccc3[nH]nc(Cc4ccc(-c5cnn(C)c5)cc4)c3c2)c1

Standard InChI:  InChI=1S/C22H20N6/c1-27-13-22(23-14-27)17-7-8-20-19(10-17)21(26-25-20)9-15-3-5-16(6-4-15)18-11-24-28(2)12-18/h3-8,10-14H,9H2,1-2H3,(H,25,26)

Standard InChI Key:  LZRZCEHXAQZTIA-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA3775519

    ---

Associated Targets(Human)

CDK8 Tchem CDK8/Cyclin C (1054 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CDK8 Tchem Cell division protein kinase 8 (1536 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver microsome (8277 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Liver microsome (4459 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 368.44Molecular Weight (Monoisotopic): 368.1749AlogP: 3.95#Rotatable Bonds: 4
Polar Surface Area: 64.32Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.75CX Basic pKa: 5.54CX LogP: 3.48CX LogD: 3.47
Aromatic Rings: 5Heavy Atoms: 28QED Weighted: 0.52Np Likeness Score: -1.31

References

1. Schiemann K, Mallinger A, Wienke D, Esdar C, Poeschke O, Busch M, Rohdich F, Eccles SA, Schneider R, Raynaud FI, Czodrowski P, Musil D, Schwarz D, Urbahns K, Blagg J..  (2016)  Discovery of potent and selective CDK8 inhibitors from an HSP90 pharmacophore.,  26  (5): [PMID:26852363] [10.1016/j.bmcl.2016.01.062]

Source